AcquisitionsMay 12, 2026, 04:23 PM
Waters Completes BDS Acquisition; Q1 Net Loss $(72)M
AI Summary
Waters Corporation completed the acquisition of Becton, Dickinson and Company's Biosciences & Diagnostic Solutions (BDS) business on February 9, 2026. This strategic acquisition significantly expanded Waters' operations and was financed partly by issuing 38,542 thousand shares of common stock, resulting in former BD shareholders owning 39.2% of Waters. For the first quarter ended April 4, 2026, Waters reported a net loss of $(72) million, or $(0.87) per basic share, a significant decline from a net income of $121 million in the prior year, despite total revenues increasing by 91.4% to $1,267 million, largely due to the inclusion of the BDS business.
Key Highlights
- Completed BDS Business Acquisition on February 9, 2026.
- Issued 38,542 thousand shares of common stock for the acquisition, valued at $12,835 million.
- Q1 2026 total revenues increased 91.4% to $1,267 million from $662 million YoY.
- Reported Q1 2026 net loss of $(72) million, down from $121 million net income YoY.
- Q1 2026 basic EPS was $(0.87), compared to $2.04 in Q1 2025.
- Total assets surged to $24,531 million from $5,077 million at year-end 2025.
- Long-term debt increased to $4,855 million from $947 million at year-end 2025.
- Net cash used in operating activities was $(3) million, down from $260 million provided YoY.